BRCA2

MRI Monitoring Reduces Breast Cancer Mortality in Women with BRCA1 Mutations

An international study published in JAMA Oncology reveals that MRI monitoring in women with BRCA1 gene mutations significantly reduces breast cancer mortality without the need for preventive mastectomy. The research, including data from 2,488 women from 59 centers in 11 countries, highlights the importance of early detection and non-invasive monitoring techniques for managing breast cancer risk in high-risk women.